AMPK activation represses the human gene promoter of the cardiac isoform of acetyl-CoA carboxylase: Role of nuclear respiratory factor-1

Biochemical and Biophysical Research Communications

Volumn 398, Issue 3, 2010, Pages 495-499

  Adam, Tasneem ^a   Opie, Lionel H ^a   Essop, M Faadiel ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Acetyl CoA carboxylase; AMPK; Fatty acid oxidation; Nuclear respiratory factor 1; Transcriptional regulation

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; NUCLEAR RESPIRATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART MUSCLE CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT;

ACETYL-COA CARBOXYLASE; ANIMALS; CELLS, CULTURED; ENZYME REPRESSION; GENES, REPORTER; HUMANS; LUCIFERASES; MYOCARDIUM; NUCLEAR RESPIRATORY FACTOR 1; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; PROTEIN KINASES; RATS; RATS, WISTAR; REPRESSOR PROTEINS; UPSTREAM STIMULATORY FACTORS;

MAMMALIA;

EID: 77955266904     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.106     Document Type: Article

References (34)

1. Zhou Y.T., Grayburn P., Karim A., Shimabukuro M., Higa M., Baetens D., Orci L., Unger R.H. Lipotoxic heart disease in obese rats: implications for human obesity. Proc. Natl. Acad. Sci. USA 2000, 97:1784-1789.
2. Szczepaniak L.S., Victor R.G., Orci L., Unger R.H. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ. Res. 2007, 101:759-767.
3. Schmitz-Peiffer C. Signalling aspects of insulin resistance in skeletal muscle: mechanisms induced by lipid oversupply. Cell Signal. 2000, 12:583-594.
4. Boudina S., Abel E.D. Diabetic cardiomyopathy revisited. Circulation 2007, 115:3213-3223.
5. Poornima I.G., Parikh P., Shannon R.P. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ. Res. 2006, 98:596-605.
6. Petersen K.F., Dufour S., Befroy D., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 2004, 350:664-671.
7. Befroy D.E., Petersen K.F., Dufour S., Mason G.F., de Graaf R.A., Rothman D.L., Shulman G.I. Impaired mitochondrial substrate oxidation in muscle of insulin-resistant offspring of type 2 diabetic patients. Diabetes 2007, 56:1376-1381.
8. McGarry J.D., Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 1997, 244:1-14.
9. Abu-Elheiga L., Jayakumar A., Baldini A., Chirala S.S., Wakil S.J. Human acetyl-CoA carboxylase: characterization, molecular cloning, and evidence for two isoforms. Proc. Natl. Acad. Sci. USA 1995, 92:4011-4015.
10. Abu-Elheiga L., Almarza-Ortega D.B., Baldini A., Wakil S.J. Human acetyl-CoA carboxylase 2. Molecular cloning, characterization, chromosomal mapping, and evidence for two isoforms. J. Biol. Chem. 1997, 272:10669-10677.
11. Abu-Elheiga L., Brinkley W.R., Zhong L., Chirala S.S., Woldegiorgis G., Wakil S.J. The subcellular localization of acetyl-CoA carboxylase 2. Proc. Natl. Acad. Sci. USA 2000, 97:1444-1449.
12. Debard C., Laville M., Berbe V., Loizon E., Guillet C., Morio-Liondore B., Boirie Y., Vidal H. Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients. Diabetologia 2004, 47:917-925.
13. Bandyopadhyay G.K., Yu J.G., Ofrecio J., Olefsky J.M. Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects. Diabetes 2006, 55:2277-2285.
14. Abu-Elheiga L., Oh W., Kordari P., Wakil S.J. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. USA 2003, 100:10207-10212.
15. Essop M.F., Camp H.S., Choi C.S., Sharma S., Fryer R.M., Reinhart G.A., Guthrie P.H., Bentebibel A., Gu Z., Shulman G.I., Taegtmeyer H., Wakil S.J., Abu-Elheiga L. Reduced heart size and increased myocardial fuel substrate oxidation in ACC2 mutant mice. Am. J. Physiol. Heart Circ. Physiol. 2008, 295:H256-H265.
16. Scarpulla R.C. Nuclear activators and coactivators in mammalian mitochondrial biogenesis. Biochim. Biophys. Acta 2002, 1576:1-14.
17. Mootha V.K., Lindgren C.M., Eriksson K.F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., Houstis N., Daly M.J., Patterson N., Mesirov J.P., Golub T.R., Tamayo P., Spiegelman B., Lander E.S., Hirschhorn J.N., Altshuler D., Groop L.C. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 2003, 34:267-273.
18. Patti M.E., Butte A.J., Crunkhorn S., Cusi K., Berria R., Kashyap S., Miyazaki Y., Kohane I., Costello M., Saccone R., Landaker E.J., Goldfine A.B., Mun E., DeFronzo R., Finlayson J., Kahn C.R., Mandarino L.J. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. USA 2003, 100:8466-8471.
19. Xia Y., Buja L.M., Scarpulla R.C., McMillin J.B. Electrical stimulation of neonatal cardiomyocytes results in the sequential activation of nuclear genes governing mitochondrial proliferation and differentiation. Proc. Natl. Acad. Sci. USA 1997, 94:11399-11404.
20. Bergeron R., Ren J.M., Cadman K.S., Moore I.K., Perret P., Pypaert M., Young L.H., Semenkovich C.F., Shulman G.I. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab. 2001, 281:E1340-E1346.
21. Oh S.Y., Lee M.Y., Kim J.M., Yoon S., Shin S., Park Y.N., Ahn Y.H., Kim K.S. Alternative usages of multiple promoters of the acetyl-CoA carboxylase beta gene are related to differential transcriptional regulation in human and rodent tissues. J. Biol. Chem. 2005, 280:5909-5916.
22. Gugneja S., Virbasius C.M., Scarpulla R.C. Nuclear respiratory factors 1 and 2 utilize similar glutamine-containing clusters of hydrophobic residues to activate transcription. Mol. Cell. Biol. 1996, 16:5708-5716.
23. Grasberger H., Ye H., Mashima H., Bell G.I. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1. Gene 2005, 344:143-159.
24. Makaula S., Adam T., Essop M.F. Upstream stimulatory factor 1 transactivates the human gene promoter of the cardiac isoform of acetyl-CoA carboxylase. Arch. Biochem. Biophys. 2006, 446:91-100.
25. Takahashi Y., Nakayama K., Itoh S., Fujii-Kuriyama Y., Kamataki T. Inhibition of the transcription of CYP1A1 gene by the upstream stimulatory factor 1 in rabbits. Competitive binding of USF1 with AhR.Arnt complex. J. Biol. Chem. 1997, 272:30025-30031.
26. Nelson T.J., Balza R., Xiao Q., Misra R.P. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy. J. Mol. Cell. Cardiol. 2005, 39:479-489.
27. Murakami T., Shimomura Y., Yoshimura A., Sokabe M., Fujitsuka N. Induction of nuclear respiratory factor-1 expression by an acute bout of exercise in rat muscle. Biochim. Biophys. Acta 1998, 1381:113-122.
28. Roepstorff C., Halberg N., Hillig T., Saha A.K., Ruderman N.B., Wojtaszewski J.F., Richter E.A., Kiens B. Malonyl-CoA and carnitine in regulation of fat oxidation in human skeletal muscle during exercise. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E133-E142.
29. Hardie D.G., Hawley S.A., Scott J.W. AMP-activated protein kinase-development of the energy sensor concept. J. Physiol. 2006, 574:7-15.
30. Gugneja S., Scarpulla R.C. Serine phosphorylation within a concise amino-terminal domain in nuclear respiratory factor 1 enhances DNA binding. J. Biol. Chem. 1997, 272:18732-18739.
31. Ussher J.R., Lopaschuk G.D. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovasc. Res. 2008, 79:259-268.
32. Sebastián D., Herrero L., Serra D., Asins G., Hegardt F.G. CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E677-686.
33. Griffin M.E., Marcucci M.J., Cline G.W., Bell K., Barucci N., Lee D., Goodyear L.J., Kraegen E.W., White M.F., Shulman G.I. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48:1270-1274.
34. Powell D.J., Turban S., Gray A., Hajduch E., Hundal H.S. Intracellular ceramide synthesis and protein kinase Czeta activation play an essential role in palmitate-induced insulin resistance in rat L6 skeletal muscle cells. Biochem. J. 2004, 382:619-629.